Post-Hoc: Lilly gets more secretive and hides Phase 1 pipeline
Eli Lilly is getting more opaque as it gets bigger. Earlier this year, the drugmaker stopped disclosing its early-stage pipeline work. Its Phase 1 projects vanished from the company’s earnings presentation and were pulled from ...
May 29, 2026 01:23 PM EDTUpdated 19 hours ago R&DPharma Post-Hoc: The world's biggest drugmaker gets more secretive Drew Armstrong Executive Editor Eli Lilly is getting more opaque as it gets bigger. Earlier this year, the drugmaker stopped disclosing its early-stage pipeline work. Its Phase 1 projects … Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that